Agilent to Showcase New Products and Innovations at HPLC 2025

Published 12/06/2025, 13:26
Agilent to Showcase New Products and Innovations at HPLC 2025

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spectrometers at the upcoming HPLC 2025 conference in Bruges, Belgium. These new additions are designed to boost laboratory efficiency and deliver superior results. Exhibition attendees will be able to see how these products can streamline operations and enhance analytical outcomes.

The Agilent null Lab Pro iQ Series, launched at ASMS 2025, represents the next generation of LC-mass detection. With innovative hardware advancements, the series delivers enhanced sensitivity and analytical performance for oligonucleotides, therapeutic peptides, and proteins”ideal for laboratories working with precious samples or low-concentration compounds. Intelligent features on the Pro iQ Single Quadrupole Mass Spectrometers provide real-time status feedback, enabling streamlined tuning and timely maintenance to reduce downtime. The system also supports advanced mass-based fraction collection, expanding its utility in compound purification workflows. Designed with sustainability in mind, it incorporates a low-maintenance, oil-free pump and has earned the new MyGreenLab ACT EcoLabel 2.0 certification.

The 1290 null III Hybrid Multisampler is equipped with both traditional flow-through injection and Agilent’s Feed Injection Mode effectively mediating sample-solvent interactions. This mode reduces the need for extensive sample preparation, saving time and ensuring superior peak shapes. Perfectly compatible with the 1300 bar null III LC system, it is capable of running methods with sub-2 µm columns. Furthermore, its biocompatibility maintains the integrity of biomolecules and minimizes unwanted surface interactions, crucial for laboratories handling sensitive biological samples.

Additional innovations:

  • Preview of fluorescence detector that requires minimal sample preparation with best-in-class sensitivity and suitable for the most challenging UHPLC applications including released glycans and aflatoxins in food. Available later this year.
  • Introduction of enhanced serviceable flow cells, null Lab Assist updates, expanded Bio Core offerings.

Early adopters of the new null III systems have already reported significant improvements in their workflows. Naresh Babu, associate vice president of Quality Assurance and Control at Novopor Advanced Science shared, It has truly enhanced the quality and efficiency of our analysis. He added, The instrument is incredibly robust, with excellent reproducibility and sensitivity.

Babu also praised the intuitive design: The user-friendly software and intuitive null Lab Assist interface make the work seamless. He further highlighted the operational benefits: We particularly appreciate the automation options available and the system’s reliability, which has significantly improved our productivity.

"We are excited to introduce our latest null III LC Series innovations at the HPLC 2025 conference, said Iris Mangelschots, vice president and general manager, Liquid Phase Division at Agilent. The introduction of the new Hybrid Multisampler and LC Single Quadrupole Mass Spectrometers illustrates our ongoing dedication to delivering innovative solutions that enhance operational workflows, improve data quality, and promote operational efficiency and sustainability in laboratories within the biopharma, industrial, and academic sectors.

Agilent’s technological advances showcased at HPLC 2025 highlight their ongoing commitment to innovation, operational efficiency, and sustainability in laboratory settings. Attendees can visit Agilent at Booth #21 to learn more about these new products and innovations from Agilent experts.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Media Contact
Catherine Kaye
Agilent Technologies
+44 (0)7775 410632
catherine.kaye@agilent.com

Source: Agilent Technologies Inc.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.